Breast cancer (BC) is categorized by receptor expression into four distinct subtypes: ER+/HER2−, ER+/HER2+, ER−/HER2+, and triple-negative breast cancer (TNBC), which generally correlate with molecular subtypes. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.